2 November 2021 in Annals of Medicine & Surgery
Systemic sclerosis is a connective tissue disease with cutaneous involvement. Clinical manifestations result from the balance of inflammations/autoimmunity process and fibrogenesis. Patients suffer from skin ulcers, non-ulcerative lesions including digital pitting scars, telangiectasias, subungual hyperkeratosis, abrasions, fissures, and subcutaneous calcinosis. A review about the pathophysiology of the disease, the physical examination of the patients, the instrumental assessment, and possible treatments is performed.
25 March 2022 in Rheumatology and Therapy
Introduction Skin ulcers (SU) represent one of the most frequent manifestations of systemic sclerosis (SSc), occurring in almost 50% of scleroderma patients. SSc-SU are often particularly difficult to treat with conventional systemic and local therapies. In this study, a preliminary evaluation of the role and effectiveness of blue light photobiomodulation (PBM) therapy with EmoLED® in the treatment of scleroderma skin ulcers (SSc-SU) was performed. Methods We retrospectively analyzed 12 consecutive SSc patients with a total of 15 SU on finger hands. All patients were treated with adequate systemic therapy and local treatment for SU; after a standard skin ulcer bed preparation with debridement of all lesions, EmoLED® was performed. All patients were locally treated every week during 2 months of follow-up; SU data were collected after 4 weeks (T4) and 8 weeks (T8). Eight SSc patients with comparable SU were also evaluated as controls. Results The application of EmoLED® in addition to debridement apparently produced faster healing of SU. Complete healing of SU was recorded in 41.6% cases during EmoLED® treatment. Significant improvements in SU area, length, and width, wound bed, and related pain were observed in EmoLED® patients from T0 to T8. Control subjects treated with standard systemic/local therapies merely showed an amelioration of SU area and width at the end of the follow-up. No procedural or post-procedural adverse events were reported. Conclusions The positive clinical results and the absence of side effects suggest that EmoLED® could be a promising tool in the management of SSc-SU, with an interesting role to play in the healing process in addition to conventional systemic and local treatments.
10 December 2025 in Osteoporosis International
Summary Indolent systemic mastocytosis (ISM) is a rare cause of skeletal fragility. In this study, patients with ISM showed a markedly higher prevalence of biconcave vertebral fractures compared with primary osteoporosis. Assessing fracture morphology may aid in differentiating ISM, reducing diagnostic delay, and guiding appropriate management. Purpose Indolent systemic mastocytosis (ISM) is a rare disorder frequently associated with bone fragility and vertebral fractures (VFx). While the morphology of VFx has been studied in other metabolic bone diseases (e.g., osteomalacia), its role in ISM remains unclear. We aimed to evaluate the prevalence of specific VFx morphologies in ISM and assess their potential diagnostic value compared with primary osteoporosis (OP). Methods We retrospectively enrolled adults with ISM and VFx, diagnosed according to WHO and ICC criteria. To increase statistical power, each ISM case was compared with two controls with OP. Clinical, densitometric, and laboratory data were collected. VFx were assessed on lateral spine X-rays (T4–L4) using Genant’s criteria and categorized as wedge or biconcave. Results Sixty-six patients were included: 22 with ISM and 44 with OP. ISM patients were younger (68 ± 8 vs. 77 ± 7 years, p < 0.001) and more frequently male (32% vs. 7%, p = 0.043). ISM patients had more VFx (median 4 vs. 3, p = 0.039) and a higher proportion of biconcave VFx (80% vs. 22%, p < 0.001). ROC analysis showed high discriminatory power for the number and proportion of biconcave VFx (AUC 0.878 and AUC 0.919, respectively) in distinguishing ISM from OP, with optimal cut-offs of > 2 biconcave VFx or > 50% of total VFx. These findings remained consistent after adjustment for age and sex. Conclusion Multiple biconcave VFx are significantly associated with ISM and may help differentiate it from primary OP. Assessment of fracture morphology could reduce diagnostic delay and guide appropriate management in patients with vertebral fragility fractures.